Literature DB >> 1758792

The effects of long-term non-fatiguing resistance exercise in subjects with post-polio syndrome.

M J Fillyaw1, G J Badger, G D Goodwin, W G Bradley, T J Fries, A Shukla.   

Abstract

Measures of torque were used to evaluate changes in muscle strength and endurance in 17 patients with post-polio syndrome who did prescribed resistance exercise for up to 2 years. Exercise compliance averaged 75%, with 16 subjects increasing the weight lifted in training. Maximum torque was significantly increased in the exercised muscle compared to the control muscle; no difference was seen in muscle endurance. Individuals with post-polio syndrome can increase muscle strength by doing non-fatiguing resistance exercise, but they should undergo quantitative testing of muscle strength a minimum of every 3 months to guard against overwork weakness.

Entities:  

Mesh:

Year:  1991        PMID: 1758792     DOI: 10.3928/0147-7447-19911101-14

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  3 in total

1.  Pain in persons with postpolio syndrome: frequency, intensity, and impact.

Authors:  Brenda L Stoelb; Gregory T Carter; Richard T Abresch; Sophia Purekal; Craig M McDonald; Mark P Jensen
Journal:  Arch Phys Med Rehabil       Date:  2008-10       Impact factor: 3.966

2.  Resistance strength training exercise in children with spinal muscular atrophy.

Authors:  Aga Lewelt; Kristin J Krosschell; Gregory J Stoddard; Cindy Weng; Mei Xue; Robin L Marcus; Eduard Gappmaier; Louis Viollet; Barbara A Johnson; Andrea T White; Donata Viazzo-Trussell; Philippe Lopes; Robert H Lane; John C Carey; Kathryn J Swoboda
Journal:  Muscle Nerve       Date:  2015-10       Impact factor: 3.217

3.  Effects of muscle strengthening and cardiovascular fitness activities for poliomyelitis survivors: A systematic review and meta-analysis.

Authors:  Akhilesh Kumar Ramachandran; Stephen P J Goodman; Michael J Jackson; Timothy J H Lathlean
Journal:  J Rehabil Med       Date:  2021-04-27       Impact factor: 2.912

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.